OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

Antzeko izenburuak

• Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
  nork: Wechsler, M, et al.
  Argitaratua: (2017)
• Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
  nork: Wechsler, M, et al.
  Argitaratua: (2017)
• Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
  nork: Benjamin Terrier, et al.
  Argitaratua: (2023-07-01)
• Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
  nork: Falk, R, et al.
  Argitaratua: (2011)
• Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
  nork: Falk, R, et al.
  Argitaratua: (2011)